Global Markets and Technologies for Advanced Drug Delivery Systems - Focus on Routes of Administration
Description
Report Scope
The current report provides detailed information on advanced drug delivery systems (ADDS). This report analyzes the market trends of ADDS with data from 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets of advanced drug delivery systems. This report highlights the advanced drug delivery systems’ current and future market potential of ADDS and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities, as well as market projections for 2030 and the market shares of leading manufacturers.
The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
The report aims to:
Companies Mentioned
Abbott
Abbvie Inc.
Amgen Inc.
Astrazeneca
Baxter
Bayer Ag
Boston Scientific Corp.
Bristol-myers Squibb Co.
F. Hoffmann-la Roche Ltd.
Gilead Sciences Inc.
Gsk Plc
Jazz Pharmaceuticals Inc.
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Pfizer Inc.
Sanofi
The current report provides detailed information on advanced drug delivery systems (ADDS). This report analyzes the market trends of ADDS with data from 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets of advanced drug delivery systems. This report highlights the advanced drug delivery systems’ current and future market potential of ADDS and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities, as well as market projections for 2030 and the market shares of leading manufacturers.
The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
The report aims to:
- Analyze types of ADDS.
- Analyze global market size and segmentation.
- Understand market constraints and drivers.
- Provide detailed market forecasts for 2030.
- Assess market shares, competitiveness and industry structure.
- Identify potential long-term impacts on the advanced drug delivery systems market.
- 170 data tables and 79 additional tables
- Overview and an analysis of the global markets and technologies for advanced drug delivery systems (ADDS) with a focus on the routes of administration (RoA)
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the advanced drug delivery systems, accompanied by a market share analysis by route of administration, technology, application, vehicle/carrier and region
- Analysis of current and future demand in the global advanced drug delivery systems market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Analysis of drivers, challenges and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
- Market share analysis of the key market participants in the advanced drug delivery systems market, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Company profiles of the leading global players, including AbbVie Inc., GSK plc, AstraZeneca, Novartis AG, Roche and Johnson & Johnson Services, Inc.
Companies Mentioned
Abbott
Abbvie Inc.
Amgen Inc.
Astrazeneca
Baxter
Bayer Ag
Boston Scientific Corp.
Bristol-myers Squibb Co.
F. Hoffmann-la Roche Ltd.
Gilead Sciences Inc.
Gsk Plc
Jazz Pharmaceuticals Inc.
Johnson & Johnson
Merck & Co. Inc.
Novartis Ag
Pfizer Inc.
Sanofi
Table of Contents
339 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Chapter 2 Market Overview
- Overview
- Macroeconomic Factors Analysis
- Impact of U.S. Tariffs on the Pharmaceutical Industry
- Healthcare Expenditure
- Aging Population
- Geopolitical Risks, Trade Wars and Supply Chain Disruptions
- Impact of Global Economic Growth (GDP) on the Pharma Sector
- Porter's Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
- Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Incidence of Chronic Diseases
- Nanotechnology in Advancing Drug Delivery
- Advances in Therapeutics and Material Science
- Increasing R&D Spending by Companies
- Rise in Government Funding and Pharmaceutical R&D Spending
- Market Restraints
- Route-Specific Barriers
- Limitations with Nanotechnology and Nanoparticles
- Challenges with Nano-drug Delivery
- Market Opportunities
- Cost-Efficiency of Advanced Drug Delivery Systems
- Mechanism of Nanoparticles in Overcoming Drug Resistance
- Emerging Markets
- Chapter 4 Regulatory Landscape
- Overview
- The U.S.
- Europe
- Asia-Pacific
- Chapter 5 Emerging Technologies and Pipeline Analysis
- Overview
- Artificial Intelligence (AI) and Machine Learning (ML)
- 3D Printing
- Smart Drug Delivery System
- Clinical Trial Analysis
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
- Key Takeaways
- Patent Analysis
- Patents, by Leading Applicant
- Patents, by Jurisdiction
- Key Takeaways
- Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Advanced Drug Delivery Systems, by Route of Administration
- Key Takeaways
- Enteral Routes
- Parenteral Routes
- Respiratory Route
- Transdermal Route
- Implants
- Ophthalmic
- Others
- Global Market for Advanced Drug Delivery Systems, by Technology
- Key Takeaways
- Targeted Release Drug Delivery
- Extended Release Drug Delivery
- Delayed Release Drug Delivery
- Immediate Release Drug Delivery
- Pulsatile Release Drug Delivery
- Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier
- Key Takeaways
- Nanoparticles
- Monoclonal Antibodies
- Liposomes
- Polymer Therapeutics
- Prodrugs
- Microparticles
- Other Vehicles/Carriers
- Global Market for Advanced Drug Delivery Systems, by Application
- Key Takeaways
- Oncology
- Cardiovascular Diseases
- Respiratory Diseases
- Autoimmune Diseases
- Inflammatory Diseases
- Metabolic Diseases
- Gastrointestinal Disorders
- Ophthalmic
- Other Applications
- Geographic Breakdown
- Global Market for Advanced Drug Delivery Systems, by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa (MEA)
- South America
- Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Landscape
- Company Share Analysis
- Chapter 8 Sustainability in the Advanced Drug Delivery Systems Market: An ESG Perspective
- Introduction to ESG
- Sustainability in the Advanced Drug Delivery Systems Market
- ESG Perspective
- Environmental Impact
- Social Impact
- Governance Impact
- ESG Risk Ratings
- Conclusion
- Chapter 9 Appendix
- Methodology
- Abbreviations
- Sources
- Company Profiles
- ABBOTT
- ABBVIE INC.
- AMGEN INC.
- ASTRAZENECA
- BAXTER
- BAYER AG
- BOSTON SCIENTIFIC CORP.
- BRISTOL-MYERS SQUIBB CO.
- F. HOFFMANN-LA ROCHE LTD.
- GILEAD SCIENCES INC.
- GSK PLC
- JAZZ PHARMACEUTICALS INC.
- JOHNSON & JOHNSON
- MERCK & CO. INC.
- NOVARTIS AG
- PFIZER INC.
- SANOFI
- Emerging Companies in the Advanced Drug Delivery Systems Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.